📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Aldagen

1.1 - Company Overview

Aldagen Logo

Aldagen

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of proprietary regenerative cell therapies addressing inherited metabolic diseases, leukemia, critical limb ischemia and ischemic heart failure. The biopharmaceutical company has four product candidates in clinical trials, including lead candidate ALD-101 in a pivotal Phase 3 trial to evaluate its efficacy.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Aldagen

Vascular Dynamics Logo

Vascular Dynamics

HQ: United States Website
  • Description: Provider of the MobiusHD endovascular implant and catheter-based EVBA procedure to modulate the baroreflex via carotid sinus placement, aiming to correct inflexible arterial motion to treat hypertension and restore autonomic balance in heart failure patients; also conducts clinical research evaluating the safety and effectiveness of MobiusHD.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vascular Dynamics company profile →
Atacor Logo

Atacor

HQ: United States Website
  • Description: Provider of extravascular cardiac lead systems enabling defibrillation, bradycardia pacing, and anti-tachycardia pacing without contacting the heart or vascular system, including the AtaCor EV-ICD Lead System and the EV Temporary Pacing Lead System that provides pacing support via a parasternal approach.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Atacor company profile →
Hotspur Logo

Hotspur

HQ: United States Website
  • Description: Provider of catheter-based technologies to restore blood flow in patients with obstructed vessels, leveraging unique, groundbreaking technology to open blood vessels more efficiently and less invasively.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Hotspur company profile →
Myocor Logo

Myocor

HQ: United States Website
  • Description: Provider of therapeutic cardiac technologies and evaluations to treat mitral regurgitation and heart failure, improving cardiac function. Offers the Coapsys System, a device and therapy for mitral valve insufficiency via a less invasive, off-pump, closed-heart procedure. Founded in 1996 and based in Minnesota.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Myocor company profile →
Longeveron Logo

Longeveron

HQ: United States Website
  • Description: Provider of cellular therapies and research programs, developing Lomecel-B, a culture-expanded medicinal signaling cell (MSC) therapy for aging-related diseases, Alzheimer’s disease, and hypoplastic left heart syndrome (HLHS), with programs testing its use in aging frailty, metabolic syndrome, and acute respiratory distress syndrome (ARDS) due to COVID-19 or influenza.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Longeveron company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Aldagen

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Aldagen

2.2 - Growth funds investing in similar companies to Aldagen

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Aldagen

4.2 - Public trading comparable groups for Aldagen

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Aldagen

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Aldagen

What does Aldagen do?

Aldagen is a provider of proprietary regenerative cell therapies addressing inherited metabolic diseases, leukemia, critical limb ischemia and ischemic heart failure. The biopharmaceutical company has four product candidates in clinical trials, including lead candidate ALD-101 in a pivotal Phase 3 trial to evaluate its efficacy.

Who are Aldagen's competitors?

Aldagen's competitors and similar companies include Vascular Dynamics, Atacor, Hotspur, Myocor, and Longeveron.

Where is Aldagen headquartered?

Aldagen is headquartered in United States.

How many employees does Aldagen have?

Aldagen has 1,000 employees 🔒.

When was Aldagen founded?

Aldagen was founded in 2010 🔒.

What sector and industry vertical is Aldagen in?

Aldagen is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Aldagen

Who are the top strategic acquirers in Aldagen's sector and industry

Top strategic M&A buyers and acquirers in Aldagen's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Aldagen?

Top strategic M&A buyers groups and sectors for Aldagen include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Aldagen's sector and industry vertical

Which are the top PE firms investing in Aldagen's sector and industry vertical?

Top PE firms investing in Aldagen's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Aldagen's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Aldagen's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Aldagen's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Aldagen include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Aldagen's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Aldagen?

The key public trading comparables and valuation benchmarks for Aldagen include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Aldagen for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Aldagen with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Aldagen's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Aldagen with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Aldagen's' sector and industry vertical?

Access recent funding rounds and capital raises in Aldagen's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Aldagen